Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leuprorelin Acetate for Doping Control Sample Generation
NCT02920359Phase 1Completed
- Sponsor
- Parc de Salut Mar
- Start
- Nov 2016
- Primary completion
- Dec 2016
- Modality
- Peptides, Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of leuprolide, sponsored by Parc de Salut Mar. Primary endpoint: Urine concentrations of leuprorelin acetate at 6 hours. Started Nov 2016; status: completed.
02
Drugs
leuprolide
Beyond the preview
Go deeper on NCT02920359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02920359.